12 (2012): Cd008650.
17. Rumpler, W., et al. “Oolong Tea Increases Metabolic Rate and Fat Oxidation in Men.” Journal of Nutrition 131, no. 11 (2001): 2848–2852.
18. Thielecke, F., and M. Boschmann. “The Potential Role of Green Tea Catechins in the Prevention of the Metabolic Syndrome – A Review.” Phytochemistry 70, no. 1 (2009): 11–24.
19. Nagao, T., et al. “A Catechin-Rich Beverage Improves Obesity and Blood Glucose Control in Patients with Type 2 Diabetes.” Obesity (Silver Spring) 17, no. 2 (2009): 310–317.
20. Iso, H., et al. “The Relationship Between Green Tea and Total Caffeine Intake and Risk for Self-Reported Type 2 Diabetes Among Japanese Adults.” Annals of Internal Medicine 144, no. 8 (2006): 554–562.
21. Panagiotakos, D. B., et al. “Long-Term Tea Intake Is Associated with Reduced Prevalence of (Type 2) Diabetes Mellitus Among Elderly People from Mediterranean Islands: MEDIS Epidemiological Study.” Yonsei Medical Journal 50, no. 1 (2009): 31–38.
22. См. примечание 13 выше.
23. Stensvold, I., et al. “Tea Consumption. Relationship to Cholesterol, Blood Pressure, and Coronary and Total Mortality.” Preventive Medicine 21, no. 4 (1992): 546–553.
24. Hodgson, J. M. “Effects of Tea and Tea Flavonoids on Endothelial Function and Blood Pressure: A Brief Review.” Clinical and Experimental Pharmacology and Physiology 33, no. 9 (2006): 838–841.
25. Yang, Y. C., et al. “The Protective Effect of Habitual Tea Consumption on Hypertension.” Archives of Internal Medicine 164, no. 14 (2004): 1534–1540.
26. Bogdanski, P., et al. “Green Tea Extract Reduces Blood Pressure, Inflammatory Biomarkers, and Oxidative Stress and Improves Parameters Associated with Insulin Resistance in Obese, Hypertensive Patients.” Nutrition Research 32, no. 6 (2012): 421–427.
27. “Tea and Cancer Prevention.” National Cancer Institute. November 17, 2010. Открыто по адресу www.cancer.gov/about-cancer/causes-prevention/risk/diet/tea-fact-sheet.
28. Wu, A. H., et al. “Tea Intake, COMT Genotype, and Breast Cancer in Asian-American Women.” Cancer Research 63, no. 21 (2003): 7526–7529.
29. Fujiki, H., et al., “Cancer Prevention with Green Tea and Its Principal Constituent, EGCG: From Early Investigations to Current Focus on Human Cancer Stem Cells.” Molecules and Cells 41, no. 2 (2018): 73–82.
1. Fragopoulou, E., C. Demopoulos, and S. Antonopoulou. “Lipid Minor Constituents in Wines. A Biochemical Approach in the French Paradox.” International Journal of Wine Research 1 (2009): 131–143.
2. Nagahori, Z. “Credibility of the Ages of Centenarians in Hunza, a Longevity Village in Pakistan.” Asian Medical Journal 25, no. 6 (1982): 405–431.
3. Ibid.
4. Hippocratic Writings, ed. G. E. R. Lloyd. London: Penguin, 2005. Открыто по адресу https://books.google.com/books?id=pg-trVeUovEC&lpg=PT93&pg=PT352#v=onepage&q&f=false.
5. См. примечание 1 выше.
6. Osborn, D. “Drink to Your Health!” Открыто по адресу www.greekmedicine.net/therapies/Drink_to_Your_Health.html.
7. Jouanna, J. Greek Medicine from Hippocrates to Galen. Leiden, The Netherlands: Brill, 2012: 173–193.
8. Goldfinger, T. M. “Beyond the French Paradox: The Impact of Moderate Beverage Alcohol and Wine Consumption in the Prevention of Cardiovascular Disease.” Cardiology Clinics 21, no. 3 (2003): 449–457.
9. Ibid.
10. Galinski, C. N., J. I. Zwicker, and D. R. Kennedy. “Revisiting the Mechanistic Basis of the French Paradox: Red Wine Inhibits the Activity of Protein Disulfide Isomerase In Vitro.” Thrombosis Research 137 (2016): 169–173.
11. См. примечание 1 выше.
12. Ibid.
13. St Leger, A. S., A. L. Cochrane, and F. Moore. “Factors Associated with Cardiac Mortality in Developed Countries with Particular Reference to the Consumption of Wine.” Lancet 1, no. 8124 (1979): 1017–1020.
14. Gronbaek, M., et al. “Mortality Associated with Moderate Intakes of Wine, Beer, or Spirits.” The BMJ 310, no. 6988 (1995): 1165–1169.
15. Renaud, S. C., et al. “Wine, Beer, and Mortality in Middle-Aged Men from Eastern France.” Archives of Internal Medicine 159, no. 16 (1999): 1865–1870.
16. Yuan, J. M., et al. “Follow Up Study of Moderate Alcohol Intake and Mortality Among Middle Aged Men in Shanghai, China.” The BMJ 1314, no. 7073 (1997): 18–23.
17. Thun, M. J., et al. “Alcohol Consumption and Mortality Among Middle-Aged and Elderly U.S. Adults.” New England Journal of Medicine 337, no. 24 (1997): 1705–1714.
18. Blackhurst, D. M., and A. D. Marais. “Alcohol – Foe or Friend?” South African Medical Journal 95, no. 9 (2005): 648–654.
19. Andreasson, S., P. Allebeck, and A. Romelsjo. “Alcohol and Mortality Among Young Men: Longitudinal Study of Swedish Conscripts.” British Medical Journal (Clinical Research Edition) 296, no. 6628 (1988): 1021–1025.
20. Djousse, L., et al. “Alcohol Consumption and Risk of Cardiovascular Disease and Death in Women: Potential Mediating Mechanisms.” Circulation 2120, no. 3 (2009): 237–244.
21. Streppel, M. T., et al. “Long-Term Wine Consumption Is Related to Cardiovascular Mortality and Life Expectancy Independently of Moderate Alcohol Intake: The Zutphen Study.” Journal of Epidemiology and Community Health 63, no. 7 (2009): 534–540.
22. Haseeb, S., B. Alexander, and A. Baranchuk. “Wine and Cardiovascular Health: A Comprehensive Review.” Circulation 136, no. 15 (2017): 1434–1448.
23. Covas, M. I., et al. “Wine and Oxidative Stress: Up-to-Date Evidence of the Effects of Moderate Wine Consumption on Oxidative Damage in Humans.” Atherosclerosis 208, no. 2 (2010): 297–304.
24. См. примечания 1 и 10 выше.
25. Biagi, M., and A. A. Bertelli. “Wine, Alcohol and Pills: What Future for the French Paradox?” Life Sciences 131 (2015): 19–22.
26. Sato, M., N. Maulik, and D. K. Das. “Cardioprotection with Alcohol: Role of Both Alcohol and Polyphenolic Antioxidants.” Annals of the New York Academy of Sciences 957 (2002): 122–135; Guiraud, A., et al. “Cardioprotective Effect of Chronic Low Dose Ethanol Drinking: Insights into the Concept of Ethanol Preconditioning.” Journal of Molecular and Cellular Cardiology 36, no. 4 (2004): 561–566; Marfella, R., et al. “Effect of Moderate Red Wine Intake on Cardiac Prognosis After Recent Acute Myocardial Infarction of Subjects with Type 2 Diabetes Mellitus.” Diabetic Medicine 23, no. 9 (2006): 974–981.
27. Karatzi, K. N., et al. “Red Wine Acutely Induces Favorable Effects on Wave Reflections and Central Pressures in Coronary Artery Disease Patients.” American Journal of Hypertension 18, no. 9 Pt 1 (2005): 1161–1167; Stranges, S., et al. “Relationship of Alcohol Drinking Pattern to Risk of Hypertension: A Population-Based Study.” Hypertension 44, no. 6 (2004): 813–819.
28. Xin, X., et al. “Effects of Alcohol Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials.” Hypertension 38, no. 5 (2001): 1112–1117.
29. Lazarus, R., D. Sparrow, and S. T. Weiss. “Alcohol Intake and Insulin Levels. The Normative Aging Study.” American Journal of Epidemiology 145, no. 10 (1997): 909–916.
30. Koppes, L. L., et al. “Moderate Alcohol Consumption Lowers the Risk of Type 2 Diabetes: A Meta-Analysis of Prospective Observational Studies.” Diabetes Care 28, no. 3 (2005): 719–725.
31. Shai, I., et al. “Glycemic Effects of Moderate Alcohol Intake Among Patients with Type 2 Diabetes: A Multicenter, Randomized, Clinical Intervention Trial.” Diabetes Care 30, no. 12 (2007): 3011–3016.
32. Corrao, G., et al. “Alcohol and Coronary Heart Disease: A Meta-Analysis.” Addiction 95, no. 10 (2000): 1505–1523.
33. Szmitko, P. E., and S. Verma. “Antiatherogenic Potential of Red Wine: Clinician Update.” American Journal of Physiology-Heart and Circulatory Physiology 288, no. 5 (2005): H2023–2030.
34. Shai, I., et al. “Glycemic Effects of Moderate Alcohol Intake Among Patients with Type 2 Diabetes: A Multicenter, Randomized, Clinical Intervention Trial.” Diabetes Care 30, no. 12 (2007): 3011–3016; Brand-Miller, J. C., et al. “Effect of Alcoholic Beverages on Postprandial Glycemia and Insulinemia in Lean, Young, Healthy Adults.” American Journal of Clinical Nutrition 85, no. 6 (2007): 1545–1551.
35. “The History of Coffee.” Сайт NCA. Открыто по адресу www.ncausa.org/about-coffee/history-of-coffee.
36. Ibid.
37. O’Keefe, J. H., et al. “Effects of Habitual Coffee Consumption on Cardiometabolic Disease, Cardiovascular Health, and All-Cause Mortality.” Journal of the American College of Cardiology 62, no. 12 (2013): 1043–1051.
38. van Dam, R. M., and F. B. Hu. “Coffee Consumption and Risk of Type 2 Diabetes: A Systematic Review.” JAMA 294, no. 1 (2005): 97–104.
39. Ohnaka, K., et al. “Effects of 16-Week Consumption of Caffeinated and Decaffeinated Instant Coffee on Glucose Metabolism in a Randomized Controlled Trial.” Journal of Nutrition and Metabolism 2012 (2012): 207426.
40. Ibid.
41. Keijzers, G. B., et al. “Caffeine Can Decrease Insulin Sensitivity in Humans.” Diabetes Care 25, no. 2 (2002): 364–369.
42. Ding, M., et al. “Caffeinated and Decaffeinated Coffee Consumption and Risk of Type 2 Diabetes: A Systematic Review and a Dose-Response Meta-Analysis.” Diabetes Care 37, no. 2 (2014): 569–586; Huxley, R., et al. “Coffee, Decaffeinated Coffee, and Tea Consumption in Relation to Incident Type 2 Diabetes Mellitus: A Systematic Review with Meta-Analysis.” Archives of Internal Medicine 169, no. 22 (2009): 2053–2063.